Literature DB >> 21872747

China's first rare-disease registry is under development.

Yan-Jun Zhang, Yi-Ou Wang, Liang Li, Jeff J Guo, Jing-Bo Wang.   

Abstract

Mesh：

Year:  2011        PMID： 21872747     DOI： 10.1016/S0140-6736(11)61375-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Study and analysis of the state of rare disease research in Shandong Province, China.

Authors:  Heng Zhao; Yazhou Cui; Xiaoyan Zhou; Jingxiang Pang; Xiumei Zhang; Shuangqing Xu; Jinxiang Han
Journal:  Intractable Rare Dis Res       Date:  2012-11

Review 2.  Rare diseases research in China: Opportunities, challenges, and solutions.

Authors:  Jinxiang Han; Yazhou Cui; Xiaoyan Zhou
Journal:  Intractable Rare Dis Res       Date:  2012-02

Review 3.  Next generation sequencing: Coping with rare genetic diseases in China.

Authors:  David S Cram; Daixing Zhou
Journal:  Intractable Rare Dis Res       Date:  2016-08

4.  Rare genetic disease in China: a call to improve clinical services.

Authors:  M Chopra; T Duan
Journal:  Orphanet J Rare Dis       Date:  2015-10-29       Impact factor: 4.123

Review 5.  A systematic review of genetic skeletal disorders reported in Chinese biomedical journals between 1978 and 2012.

Authors:  Yazhou Cui; Heng Zhao; Zhenxing Liu; Chao Liu; Jing Luan; Xiaoyan Zhou; Jinxiang Han
Journal:  Orphanet J Rare Dis       Date:  2012-08-22       Impact factor: 4.123

6.  Characteristics of Japanese Duchenne and Becker muscular dystrophy patients in a novel Japanese national registry of muscular dystrophy (Remudy).

Authors:  Harumasa Nakamura; En Kimura; Madoka Mori-Yoshimura; Hirofumi Komaki; Yu Matsuda; Kanako Goto; Yukiko K Hayashi; Ichizo Nishino; Shin'ichi Takeda; Mitsuru Kawai
Journal:  Orphanet J Rare Dis       Date:  2013-04-19       Impact factor: 4.123

7.  Access to Orphan Drugs is a Challenge for Sustainable Management of Cystinosis in China.

Authors:  Xiao-Qiao Li; Xiao-Xia Peng; Chun-Xiu Gong
Journal:  Chin Med J (Engl)       Date:  2018-10-05       Impact factor: 2.628
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.